SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-008657
Filing Date
2019-06-04
Accepted
2019-06-04 16:05:40
Documents
21
Period of Report
2019-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35950
2 ex99-1.htm EX-99.1 23780
3 ex99-1_001.jpg GRAPHIC 47808
4 ex99-1_002.jpg GRAPHIC 171837
5 ex99-1_003.jpg GRAPHIC 132978
6 ex99-1_004.jpg GRAPHIC 105018
7 ex99-1_005.jpg GRAPHIC 123090
8 ex99-1_006.jpg GRAPHIC 117611
9 ex99-1_007.jpg GRAPHIC 101091
10 ex99-1_008.jpg GRAPHIC 130430
11 ex99-1_009.jpg GRAPHIC 92996
12 ex99-1_010.jpg GRAPHIC 122387
13 ex99-1_011.jpg GRAPHIC 143999
14 ex99-1_012.jpg GRAPHIC 139528
15 ex99-1_013.jpg GRAPHIC 128319
16 ex99-1_014.jpg GRAPHIC 110823
17 ex99-1_015.jpg GRAPHIC 144182
18 ex99-1_016.jpg GRAPHIC 110058
19 ex99-1_017.jpg GRAPHIC 62808
20 ex99-1_018.jpg GRAPHIC 178501
21 ex99-1_019.jpg GRAPHIC 73895
  Complete submission text file 0001493152-19-008657.txt   3144028
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 19876623
SIC: 2834 Pharmaceutical Preparations